SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950142-24-001307
Filing Date
2024-05-08
Accepted
2024-05-08 16:42:49
Documents
14
Period of Report
2024-05-08
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K eh240479488_8k.htm   iXBRL 8-K 22978
2 EXHIBIT 99.1 eh240479488_ex9901.htm EX-99.1 22154
  Complete submission text file 0000950142-24-001307.txt   226588

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE inbx-20240508.xsd EX-101.SCH 3012
4 XBRL LABEL FILE inbx-20240508_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE inbx-20240508_pre.xml EX-101.PRE 22357
17 EXTRACTED XBRL INSTANCE DOCUMENT eh240479488_8k_htm.xml XML 3686
Mailing Address 11025 N. TORREY PINES ROAD, SUITE 200 LA JOLLA CA 92037
Business Address 11025 N. TORREY PINES ROAD, SUITE 200 LA JOLLA CA 92037 (858) 795-4220
Inhibrx, Inc. (Filer) CIK: 0001739614 (see all company filings)

IRS No.: 824257312 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39452 | Film No.: 24926966
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)